Cencora
Cencora is a leading global pharmaceutical sourcing and distribution services provider that bridges the gap between manufacturers and healthcare providers. The company optimizes the pharmaceutical supply chain by delivering brand-name, generic, and specialty medications alongside clinical and commercialization services. Its core value proposition lies in enhancing patient access to care while improving operational efficiency for both human and animal health markets.
Financials
Based on Q1 2026 · FQ2 FY2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
U.S. Healthcare Solutions
primaryDistributes a comprehensive range of brand-name, specialty, and generic pharmaceuticals, as well as over-the-counter products and home healthcare supplies. It also provides practice management, pharmacy automation, and consulting services to healthcare providers and manufacturers in the United States.
Good Neighbor Pharmacy, Elevate Provider Network, Retina Consultants of America (RCA), MWI Animal Health, OneOncology
Acute care hospitals, Retail pharmacies, Physician practices, Veterinarians, Mail order pharmacies
International Healthcare Solutions
majorFocuses on international pharmaceutical wholesale and global commercialization services, primarily in Europe and Canada. This segment includes specialty transportation, logistics, and specialized consulting services for the life sciences industry.
Alliance Healthcare, World Courier, Innomar, PharmaLex
Global pharmaceutical manufacturers, Biotech companies, European pharmacies, Hospitals, Health centers
Segment Financials
U. S. Healthcare Solutions — Revenue
View metricU. S. Healthcare Solutions — Total segment cost of goods sold
View metricU. S. Healthcare Solutions — Total segment operating income
View metricInternational Healthcare Solutions — Total segment cost of goods sold
View metricInternational Healthcare Solutions — Revenue
View metricInternational Healthcare Solutions — Total segment operating income
View metricBusiness Overview
Competitive Position
Cencora is one of the three largest national pharmaceutical distributors in the U.S. and maintains a leading global position in specialty logistics and international wholesale.
Geographies
United States, Canada, Europe, Turkey, Brazil
Customer Segments
Healthcare providers, Pharmaceutical manufacturers, Retail pharmacy chains, Veterinary clinics
Upstream Dependencies
Brand-name pharmaceutical manufacturers, Generic drug manufacturers, Biotechnology companies, Medical equipment manufacturers
Downstream Customers
Retail drugstore chains, Independent community pharmacies, Health systems and hospitals, Physician specialists, Veterinary practices
Competitors & Partners
Competitors
McKesson
MCK
Primary competitor in U.S. pharmaceutical distribution and specialty services.
United Parcel Service, Inc.
UPS
Competitor in healthcare logistics and specialty transportation.
Cardinal Health
CAH
Major competitor in pharmaceutical distribution and healthcare solutions.
AbbVie
ABBV
Major wholesale distributor (customer/partner context)
Eli Lilly
LLY
Major distributor (also listed as a customer)
Partners
Cigna
CI
Significant customer accounting for a major portion of annual revenue.
TPG Inc.
TPG
Joint venture partner in the acquisition of OneOncology.
Sycamore Partners
Private equity firm that acquired WBA, impacting the strategic relationship.
Subsidiaries
Retina Consultants of America
Management services organization for retina specialists acquired in 2025.
Alliance Healthcare
International pharmaceutical wholesale and distribution business.
World Courier
Specialty logistics and transportation provider for the biopharmaceutical industry.
MWI Animal Health
Animal health distribution and services business.
PharmaLex
Specialized services provider for the life sciences industry.
Cencora FAQ
Common questions about Cencora
Cencora is a leading global pharmaceutical sourcing and distribution services provider that bridges the gap between manufacturers and healthcare providers. The company optimizes the pharmaceutical supply chain by delivering brand-name, generic, and specialty medications alongside clinical and commercialization services. Its core value proposition lies in enhancing patient access to care while improving operational efficiency for both human and animal health markets.
Cencora (COR) has a market capitalization of $50.8B and trades on NYSE.
Cencora generated $328.68B in trailing twelve-month revenue with net income of $3.6B, representing a net margin of 1.1%. Gross margin stands at 3.8%, with free cash flow of $1.6B. These figures are based on the Q1 2026 filing.
Cencora's key competitors include McKesson Corporation, UPS Logistics, Cardinal Health, Inc., and others. These companies compete in similar markets and product categories.
Cencora has approximately 46,000 employees.